ARYLTHIOACETAMIDE CARBOXYLATE DERIVATIVES AS FKBP INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
申请人:Pellecchia Maurizio
公开号:US20080293721A1
公开(公告)日:2008-11-27
The present invention provides compounds having the general structure I, or a pharmaceutically acceptable salt thereof:
wherein Z is selected from a group consisting of O, C, N, and S; each of Ar
1
, Ar
2
, and Ar
3
is a moiety selected from a group consisting of an aryl and a substituted aryl; Y is selected from a group consisting of S, O, CH
2
and SO
2
; K is selected from a group consisting CH
2
, CF
2
, O, NH, and SO
2
; each of n
1
and n
2
is an integer selected from a group consisting of 0, 1, 2, 3, and 4; and each of x, y, m
1
and m
2
is an integer selected from a group consisting of 0 and 1. Pharmaceutical compositions based on compounds I are also provided for treatment of a neurological disorders, diseases, or pathologies, and for treatment of infectious diseases.
本发明提供具有一般结构I或其药学上可接受的盐的化合物:其中Z从O、C、N和S的群中选择;Ar1、Ar2和Ar3中的每一个是从芳基和取代芳基的群中选择的基团;Y从S、O、CH2和SO2的群中选择;K从CH2、CF2、O、NH和SO2的群中选择;n1和n2中的每一个是从0、1、2、3和4的群中选择的整数;x、y、m1和m2中的每一个是从0和1的群中选择的整数。还提供基于化合物I的药物组合物,用于治疗神经系统疾病、疾病或病理以及感染性疾病的治疗。